Medical and Pharmaceutical Replimune tanks on FDA concerns about its skin cancer therapy Shares slid by more than 37% at the intraday low on Tuesday Rowan DunneJuly 29, 2026
Medical and Pharmaceutical The next front against cancer: A Mugglehead roundup The fight is far from over, and each year brings new strategies, technologies, and therapies Joseph MortonDecember 23, 2025
AI and Autonomy Median Technologies and European Investment Bank agrees to €37.5M loan The tech leverages machine learning to analyze imaging data generated by low-dose computed tomography Joseph MortonJanuary 28, 2025
Medical and Pharmaceutical Phio Pharmaceuticals skyrockets on skin cancer drug trial success Shareholders are having a pretty stellar Monday with the immense gains Rowan DunneJanuary 13, 2025